AbCellera Biologics Inc (FRA:8QQ)
€ 2.3 -0.207 (-8.26%) Market Cap: 738.84 Mil Enterprise Value: 213.04 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 71/100

Abcellera Biologics Inc at Bloom Burton & Co Healthcare Investor Conference Transcript

Apr 25, 2023 / 01:30PM GMT
Release Date Price: €6.43 (-1.23%)
Unidentified Participant

2023 Bloom Burton Healthcare Investor Conference. This morning, we have five presentations in this meeting room C/D. Our first presentation will be from AbCellera Biologics, presented by their CEO, Carl Hansen. Followed by Carl's presentation, there will be a five-minute Q&A. (Conference Instructions) Take it away, Carl.

Carl Hansen
AbCellera Biologics Inc. - Chairman, President & CEO

Thank you so much. It's always a pleasure to be here. I want to thank Bloom Burton for putting on a great show again. Whoops, the disclaimers.

So, I thought I'd start by maybe giving a little perspective. It's an honor to get to give the opening talk here in the Canadian life science ecosystem. I was thinking this morning about when we first started the company 10 years ago, and looking at some of the top companies back then -- I think Zymeworks was probably one of the top ones -- and imagining, hey, what would it feel like to be in that position when you're starting from a small group of, let's say, six people.

So, here I stand today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot